hpFSH + hMG

This drug is a combination of highly purified follicle-stimulating hormone (hpFSH) and human menopausal gonadotropin (hMG). Both are injectable gonadotropins used in assisted reproductive technology (ART), particularly for controlled ovarian stimulation in women undergoing procedures such as in vitro fertilization (IVF). - hpFSH is a recombinant or highly purified urinary preparation of the pituitary hormone FSH, which stimulates the growth and maturation of ovarian follicles. - hMG contains both FSH and luteinizing hormone (LH) activity, typically derived from the urine of postmenopausal women. It supports follicular development by providing both FSH and LH activity, which are essential for estrogen production and ovulation induction[1][4][8]. The combination aims to optimize follicular recruitment, oocyte maturation, and steroidogenesis during ART cycles. Clinical studies have evaluated this combination for its effects on oocyte yield, embryo quality, implantation rates, and pregnancy outcomes[2][3][6][7].

Other names

HPFSH + HMGhighly purified follicle-stimulating hormone + human menopausal gonadotropin